Loading...

Home
ETF
ONCY

ONCY

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ONCY News

Oncolytics Biotech Adjusts Clinical Trial Strategy

Feb 24 2026seekingalpha

Global Oncology Market Expected to Reach $748.17 Billion

Feb 24 2026PRnewswire

Global Oncology Market Expected to Reach $748.17 Billion

Feb 24 2026Newsfilter

Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment

Feb 17 2026PRnewswire

Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment

Feb 17 2026PRnewswire

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep

Feb 17 2026Newsfilter

FDA's Accelerated Approval Framework Drives Cancer Treatment Advances

Feb 17 2026Newsfilter

Oncolytics Biotech Receives FDA Fast Track Designation

Feb 05 2026PRnewswire

Precision Biologics Market Awakens to $71 Billion Opportunity

Feb 05 2026Globenewswire

FDA Accelerates Oncology Drug Approvals, Boosting Market Potential

Feb 05 2026Newsfilter

Precision Biologics Market Awakens to $71 Billion Opportunity

Feb 05 2026Newsfilter

Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep

Feb 04 2026seekingalpha

Oncolytics Receives FDA Fast Track Designation for Pelareorep

Feb 04 2026Newsfilter

Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge

Jan 30 2026PRnewswire

Oncolytics Biotech's Breakthroughs in Cancer Treatment

Jan 30 2026PRnewswire

Oncolytics Biotech Strengthens Leadership Amid FDA Approval Surge

Jan 30 2026Newsfilter